REFERENCES
- End Results in Cancer Report No. 3. U.S. Department of Health, Education, and Welfare, Public Health Service. Washington, D.C., U.S. Government Printing Office, 1968.
- Hearings before the Subcommittee on the Departments of Labor and Health, Education, and Welfare, Committee on Appropriations, United States Senate, Ninety-First Congress, First Session on H.R. 13111. Washington, D.C., U.S. Government Printing Office, 1969, p 1162.
- Zubrod, C. G., Schepartz, S., Leiter, J., Endicott, K. M., Carrese, L. M. and Baker, C. G.: The chemotherapy program of the National Cancer Institute: History, analysis and plans. Cancer Chemother Rep 50: 348, 1966.
- Goldin, A., Venditti, J. M., Humphreys, S. R. and Mantel, N.: Modification of treatment schedules in the management of advanced mouse leukemia with amethopterin. J Nat Cancer Inst 17: 203, 1956.
- Schein, P. S., Davis, R. D., Carter, S., Newman, J., Schein, D. R. and Rall, D. P.: Commentary: The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man. Clin Pharmacol Ther 11: 3, 1970.
- Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H. and Skipper, H. E.: Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man. Cancer Chemother Rep 50: 219, 1966.
- Carrese, I. M. and Baker, C. G.: The convergence technique—a method for the planning and programming of research efforts. Management Sci 13: B420, 1967.
- Armitage, P.: Sequential Medical Trials. Springfield, 111., Charles C Thomas, Publisher, 1961.